Literature DB >> 24835133

[The functions of CD4+CD25-LAG3+ regulatory T cells and Egr2 in the regulation of autoimmunity].

Keishi Fujio1, Tomohisa Okamura, Shuji Sumitomo, Kazuhiko Yamamoto.   

Abstract

Regulatory T cells (Treg) are important mechanisms that regulate autoimmunity and CD4+CD25+Foxp3+ regulatory T cells (CD25+Treg) have been extensively investigated. Recently, we have identified CD4+CD25-LAG3+ regulatory T cells (LAG3+Treg) that express an anergy associated transcription factor Egr2. Egr2 regulates IL-10 production in response to IL-27, and Egr2-deficiency in T cells and B cells results in systemic autoimmunity with increased IL-17 production. Moreover, addition of Egr3 deficiency to Egr2-deficient mice significantly accelerates systemic autoimmunity without functional impairment of CD25+Treg, indicating cooperative autoimmune-regulation by Egr2 and Egr3. The linkage between Egr2 and systemic autoimmunity is also suggested by the fact that stimulation with Ly108, a candidate lupus susceptibility gene in lupus-prone NZM2410 mice, induces Egr2 expression in T cells. Collectively, LAG3+Treg and Egr2 are the unique regulators of autoimmunity and further examination may help to understand and control immune responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24835133     DOI: 10.2177/jsci.37.69

Source DB:  PubMed          Journal:  Nihon Rinsho Meneki Gakkai Kaishi        ISSN: 0911-4300


  2 in total

1.  Wogonin Suppresses IL-10 Production in B Cells via STAT3 and ERK Signaling Pathway.

Authors:  Li Fan; Dongbo Qiu; Guo Huang; Jingrou Chen; Qiongli Wu; Shiqiu Xiong; Changyou Wu; Yanwen Peng; Qi Zhang
Journal:  J Immunol Res       Date:  2020-06-01       Impact factor: 4.818

2.  Changes in DNA Methylation from Age 18 to Pregnancy in Type 1, 2, and 17 T Helper and Regulatory T-Cells Pathway Genes.

Authors:  Sabrina Iqbal; Gabrielle A Lockett; John W Holloway; S Hasan Arshad; Hongmei Zhang; Akhilesh Kaushal; Sabarinath R Tetali; Nandini Mukherjee; Wilfried J J Karmaus
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.